Clinical Roundup Phase III data demonstrate Alecensa reduces disease recurrence in the early setting for ALK-positive NSCLC September 08, 2023Vol.49 No.33
Clinical Roundup Merck’s Welireg reached primary endpoint of PFS in phase III trial for RCC September 08, 2023Vol.49 No.33
Clinical Roundup Siteman: Robotic technology allows for earlier, more accurate lung cancer diagnosis September 08, 2023Vol.49 No.33
Clinical Roundup UAMS study finds many rural women cancer patients receive financial support through social networks September 08, 2023Vol.49 No.33
Clinical Roundup UPMC “weighted” lottery program improved equity in allocation of scarce medication September 08, 2023Vol.49 No.33
Clinical Roundup City of Hope researchers identify biomarkers that may detect risk of advanced prostate cancer in Black men September 08, 2023Vol.49 No.33
Clinical Roundup Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models September 08, 2023Vol.49 No.33
Clinical Roundup Researchers develop molecular design for enhanced efficacy and safety in radiotheranostics September 08, 2023Vol.49 No.33
Clinical RoundupFree City of Hope researchers develop a CAR T-cell therapy for advanced ovarian cancer, now in phase I August 11, 2023Vol.49 No.32
